MR
Mary Relling is a researcher at St. Jude Children's Research Hospital whose work focuses on pharmacogenomics and pharmacokinetics in pediatric oncology. She studies how genetic variation influences drug response and toxicity, particularly in the treatment of acute lymphoblastic leukemia.
- Field
- Medicine · Pharmacy and Pharmacology
- Clarivate categories
- Pharmacology and Toxicology
- Affiliation
- St Jude Children's Research Hospital, United States